Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial
JAMA Network Open, 2023-04, Vol.6 (4), p.e237243-e237243 [Peer Reviewed Journal]Copyright 2023 Fanlo P et al. . ;ISSN: 2574-3805 ;EISSN: 2574-3805 ;DOI: 10.1001/jamanetworkopen.2023.7243 ;PMID: 37027155
Full text available